Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.24 +0.07%   SPY: 167.23 +0.18%
Quote Spy PSTI NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Pluristem Therapeutic (PSTI)

@ 12:07 PM
Click the portfolio to add PSTI:
Close [X]
+ Add PSTI to Portfolio
  
  Last Trade: $2.99 -0.01 (-0.33%)
  Volume: 102,707 152% of avg daily volume
       
  Avg Volume: 125,276
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 2.98 - 3.07
  Open: 3.05
  Previous Close: 3.00
  52-wk Range: 2.26 - 5.00
  Market Cap: 176.0M
  P/E: -8.3
  Div Yield: $0.00 (0.00%)
Indexes
Stem Cell Stocks (+3.6%)
Spy PSTI

? Pro holders
? Member holders
? Items submitted
Additional PSTI resources



Customize Links
To see which Pros and tickerspy members own PSTI Sign up now
Latest PSTI Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013
PSTI  
Linked by GlobeNewswire - April 30, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 30, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension
PSTI  
Linked by GlobeNewswire - April 29, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine
PSTI  
Linked by GlobeNewswire - April 18, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension
PSTI  
Linked by GlobeNewswire - April 11, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 11, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
United Therapeutics Moves Forward Towards a Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension
PSTI  
Linked by GlobeNewswire - February 26, 09:13AM from (globenewswire.com)
HAIFA, Israel, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
CORRECTING AND REPLACING -- Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13
PSTI  
Linked by GlobeNewswire - February 13, 08:13AM from (globenewswire.com)

HAIFA, Israel, Feb. 13, 2013 (GLOBE NEWSWIRE) -- In a release issued earlier today by Pluristem Therapeutics Inc.  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13
PSTI  
Linked by GlobeNewswire - February 13, 03:13AM from (globenewswire.com)
HAIFA, Israel, Feb. 13, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and Clinical Trial Use
PSTI  
Linked by GlobeNewswire - November 07, 06:13AM from (globenewswire.com)
HAIFA, Israel, Nov. 7, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem Issues Letter to Shareholders Highlighting Significant Achievements on Several Fronts
PSTI  
Linked by GlobeNewswire - October 09, 05:00AM from (www.globenewswire.com)

HAIFA, Israel, Oct. 9, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem Develops Point-of-Care Thawing Device for PLX Cells
PSTI  
Linked by GlobeNewswire - October 04, 04:00AM from (www.globenewswire.com)
HAIFA, Israel, Oct. 4, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 11



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource